A 10-aa motif in transmembrane helix 1 of diphtheria toxin that is conserved in anthrax edema factor, anthrax lethal factor, and botulinum neurotoxin serotypes A, C, and D was identified by BLAST, CLUSTAL W, and MEME computational analysis. Using the diphtheria toxin-related fusion protein toxin DAB 389IL-2, we demonstrate that introduction of the L221E mutation into a highly conserved residue within this motif results in a nontoxic catalytic domain translocation deficient phenotype. To further probe the function of this motif in the process by which the catalytic domain is delivered from the lumen of early endosomes to the cytosol, we constructed a gene encoding a portion of diphtheria toxin transmembrane helix 1, T1, which carries the motif and is expressed from a CMV promoter. We then isolated stable transfectants of Hut102͞6TG cells that express the T1 peptide, Hut102͞6TG-T1. In contrast to the parental cell line, Hut102͞6TG-T1 cells are ca. 10 4 -fold more resistant to the fusion protein toxin. This resistance is completely reversed by coexpression of small interfering RNA directed against the gene encoding the T1 peptide in Hut102͞ 6TG-T1 cells. We further demonstrate by GST-DT140-271 pull-down experiments in the presence and absence of synthetic T1 peptides the specific binding of coatomer protein complex subunit  to this region of the diphtheria toxin transmembrane domain.early endosomes ͉ translocation ͉ ADP-ribosyltransferase ͉ coatomer protein complex subunit  T he intoxication of eukaryotic cells by diphtheria toxin follows an ordered series of interactions between the toxin and cellular factors that lead to inhibition of protein synthesis and cell death (1). Biochemical, genetic, and x-ray crystallographic analysis of the toxin has shown the protein to be composed of three distinct domains: an N-terminal catalytic (C) domain, a central transmembrane (T) domain, and the C-terminal receptor-binding domain (2-5). The intoxication process is initiated by the binding of the toxin to its cell surface receptor, a heparin binding epidermal growth factor-like precursor, and CD9 (6, 7). Once bound to its receptor, the toxin is internalized by receptormediated endocytosis into an early endosomal compartment (8). Upon acidification of the endosomal lumen by vesicular ATPase, the T domain undergoes a conformational change and spontaneously inserts into the vesicular membrane, forming an 18-to 22-Å pore or channel (9, 10). It is widely believed that the C domain, in a fully denatured form, is specifically thread through this channel and released into the cytosol. Once the C domain is refolded into an active conformation, it catalyzes the NAD ϩ -dependent ADP ribosylation of elongation factor 2 (EF-2), causing irreversible inhibition of protein synthesis and death of the cell by apoptosis (11,12). Although the endosomal membrane translocation of the C domain is understood in broad terms, the precise molecular mechanism(s) of this step in the intoxication process has remained largely unknown.Two hypotheses for C ...